Benralizumab recalls

The FDA has published 1 recall involving Benralizumab since 2025. The latest was reported on 22 Oct 2025. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2025
Last 12 months0reported
Class I00% of total
Ongoing1latest 22 Oct 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why benralizumab is recalled

By year

Ongoing benralizumab recalls

1 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIFasenra (benralizumab) Injection, 30 mg/mL recalledFasenraAstrazeneca PharmaceuticalsSterilityNationwide

All benralizumab recalls, newest first

1 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIFasenra (benralizumab) Injection, 30 mg/mL recalledFasenraAstrazeneca PharmaceuticalsSterilityNationwide

Should you stop taking Benralizumab?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.